Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Shigella flexneri 2a Invaplex 50 vaccine dose finding and assessment of protection

Trial Profile

Shigella flexneri 2a Invaplex 50 vaccine dose finding and assessment of protection

Completed
Phase of Trial: Phase I/II

Latest Information Update: 22 Jul 2011

At a glance

  • Drugs Shigella flexneri 2A vaccine (Primary)
  • Indications Diarrhoea; Dysentery; Fever; Shigella infections
  • Focus Pharmacodynamics
  • Most Recent Events

    • 22 Jul 2011 Results published in Vaccine.
    • 01 Dec 2010 Planned end date (Jul 2009) added as reported by ClinicalTrials.gov.
    • 01 Dec 2010 Actual initiation date (May 2007) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top